Sonoma Pharmaceuticals, Inc.
SNOA
$1.33
$0.010.38%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -330.00K | -581.00K | -819.00K | -534.00K | -1.24M |
| Total Depreciation and Amortization | 32.00K | 33.00K | 34.00K | 36.00K | 36.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 98.00K | -258.00K | -78.00K | 143.00K | -298.00K |
| Change in Net Operating Assets | -449.00K | 287.00K | 99.00K | -280.00K | -512.00K |
| Cash from Operations | -649.00K | -519.00K | -764.00K | -635.00K | -2.02M |
| Capital Expenditure | -2.00K | -29.00K | -47.00K | -10.00K | -106.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2.00K | -29.00K | -47.00K | -10.00K | -106.00K |
| Total Debt Issued | -- | 277.00K | -- | -- | -- |
| Total Debt Repaid | -82.00K | -51.00K | -56.00K | -83.00K | -81.00K |
| Issuance of Common Stock | 3.54M | 161.00K | 266.00K | 21.00K | 23.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.45M | 387.00K | 210.00K | -62.00K | -58.00K |
| Foreign Exchange rate Adjustments | 136.00K | -1.00K | 127.00K | 137.00K | 410.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.94M | -162.00K | -474.00K | -570.00K | -1.77M |